Chemical formula: C₂₃H₂₇Cl₂N₃O₂ Molecular mass: 448.385 g/mol PubChem compound: 60795
Aripiprazole is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Oral aripiprazole is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Aripiprazole prolonged-release suspension for injection is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 - 65 years old)
Aripiprazole is indicated for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Aripiprazole is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder in adults.
Aripiprazole is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Aripiprazole is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.